Mike Rubin, co-founder and vice president of business development for Compassionate Cultivation, stands in the company's dispensary.
Note: This post was corrected Sept. 13, 2019 to reflect that all patients with prescriptions may access the new product, not only patients with terminal cancer.
Compassionate Cultivation, one of three Texas dispensaries licensed to sell medical-grade cannabis under Texas' Compassionate Use Act, has expanded its products to offer a tincture with a ratio of 3-1 CBD to THC. According to an Aug. 29 press release from the company, the first patient to receive the new tincture was Charlotte Friedley, a patient with non-Hodgkin’s lymphoma.
This tincture represents the highest-THC formulation that Compassionate Cultivation has issued to date, compared to the 3-1 THC to CBD formulation previously offered exclusively to patients with intractable epilepsy. The new formula follows the Texas Legislature's updated guidelines for legal sales of medical cannabis to patients with a wider range of conditions, including multiple sclerosis, autism and terminal cancer.
Olivia hosts and produces Community Impact Newspaper's podcasts, the Austin Breakdown, the Houston Breakdown and the DFW Breakdown. She launched the podcasts after nearly three years as a reporter for the newspaper, covering public health, business, development and Travis County government for the Central Austin edition. Olivia worked as a reporter and producer for South Carolina Public Radio before moving to Texas. You can follow her on Twitter @ojaldridge.